These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
82 related items for PubMed ID: 6449286
1. Immunoprophylactic and immunotherapeutic response by concanavalin A-bound tumor vaccine enhanced by chemotherapeutic agents eliminating possible suppressors. Kataoka T, Ogihara K, Sakurai Y. Cancer Res; 1980 Oct; 40(10):3839-45. PubMed ID: 6449286 [Abstract] [Full Text] [Related]
2. In vivo potentiation of concanavalin A-bound L1210 vaccine by antimacrophage agents. Kataoka T, Oh-hashi F, Sakurai Y, Gomi K. Cancer Res; 1980 Oct; 40(10):3832-8. PubMed ID: 6254642 [Abstract] [Full Text] [Related]
3. Immunotherapeutic response of concanavalin A-bound L1210 vaccine enhanced by a streptococcal immunopotentiator, OK-432. Kataoka T, Oh-hashi F, Sakurai Y. Cancer Res; 1979 Jul; 39(7 Pt 1):2807-10. PubMed ID: 445486 [Abstract] [Full Text] [Related]
4. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine. Kataoka T, Akahori Y, Sakurai Y. Cancer Res; 1984 Feb; 44(2):519-24. PubMed ID: 6537896 [Abstract] [Full Text] [Related]
5. Blastogenic potency of concanavalin-A-bound L1210 leukemic vaccine associated with its immunogenic activity. Kataoka T, Oh-hashi F, Sakurai Y. Gan; 1979 Apr; 70(2):155-64. PubMed ID: 111995 [Abstract] [Full Text] [Related]
6. Immunogenicity and amplifier cell production by tumor vaccines enhanced by concanavalin A. Kataoka T, Oh-Hashi F, Sakurai Y. Gan; 1982 Apr; 73(2):193-205. PubMed ID: 6811360 [Abstract] [Full Text] [Related]
7. Enhanced induction of immune resistance by concanavalin A-bound L1210 vaccine and an immunopotentiator prepared from Coriolus versicolor. Kataoka T, Oh-hashi F, Tsukagoshi S, Sakurai Y. Cancer Res; 1977 Dec; 37(12):4416-9. PubMed ID: 922733 [Abstract] [Full Text] [Related]
8. Production of antitumor T-cells in tumor-bearing mice treated with tumor vaccine and 6-mercaptopurine. Kataoka T, Oh-hashi F. Cancer Res; 1985 Jul; 45(7):2962-6. PubMed ID: 3873988 [Abstract] [Full Text] [Related]
9. Potentiation of L1210 murine leukemia vaccine in vivo by levamisole. Kataoka T, Tsukagoshi S, Sakurai Y, Okabe M. Gan; 1979 Aug; 70(4):515-9. PubMed ID: 510850 [Abstract] [Full Text] [Related]
10. Potentiation of concanavalin A-bound L1210 vaccine in vivo by chemotherapeutic agents. Kataoka T, Kobayashi H, Sakurai Y. Cancer Res; 1978 May; 38(5):1202-7. PubMed ID: 639053 [No Abstract] [Full Text] [Related]
11. Mitomycin C-augmented production of I-A antigen-positive macrophages in tumor vaccine-primed mice. Kataoka T, Yamamoto T, Honjo K, Murayama T. Jpn J Cancer Res; 1986 Mar; 77(3):305-11. PubMed ID: 3009373 [Abstract] [Full Text] [Related]
16. Induction of transplantation resistance to murine L1210 leukemia cells in BCG-primed mice by immunization with tuberculin protein-coupled L1210 cells. Ohno R, Kodera Y, Ogura M, Yamada H. Gan; 1984 Feb; 75(2):187-92. PubMed ID: 6428959 [Abstract] [Full Text] [Related]
19. Synergistic effect of metronomic dosing of cyclophosphamide combined with specific antitumor immunotherapy in a murine melanoma model. Hermans IF, Chong TW, Palmowski MJ, Harris AL, Cerundolo V. Cancer Res; 2003 Dec 01; 63(23):8408-13. PubMed ID: 14679003 [Abstract] [Full Text] [Related]
20. Chemotherapy and immunotherapy of L1210 leukemic mice with antigenic tumor sublines. Nicolin A, Canti G, Marelli O, Veronese F, Goldin A. Cancer Res; 1981 Apr 01; 41(4):1358-62. PubMed ID: 7011535 [Abstract] [Full Text] [Related] Page: [Next] [New Search]